Evidence map›Paper›PMID 11179286›Full record

ArticleInfection and immunity2001

Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.

M M Dinges, P M Schlievert

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. A promisingClinical and experimental vaccine research · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Device-Associated Menstrual Toxic Shock Syndrome.Clinical microbiology reviews · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M M DingesDepartment of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
P M Schlievert
University of Minnesota Medical Center · US

Funding

Molecular Biology of TSST-1 and other superantigen toxinsR01AI022159 · NIAID · PUBLIC HEALTH RESEARCH INSTITUTE · PI NOVICK, RICHARD P. · 1985 to 2014
$2.6M
MOLECULAR BIOLOGY OF TSST-1 &OTHER SUPERANTIGEN TOXINSR37AI022159 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NOVICK, RICHARD P. · 1996 to 2005
$2.1M
MOLECULAR MECHANISMS OF INFECTIOUS DISEASE TRAININGT32AI007421 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HAASE, ASHLEY T. · 1995 to 2004
$1.2M
NIAID NIH HHS AI07421NIAID NIH HHS AI22159NIAID NIH HHS R01 AI022159NIAID NIH HHS R37 AI022159NIAID NIH HHS T32 AI007421
6 · The paper itself

Abstract

The superantigenic function of toxic shock syndrome toxin 1 (TSST-1) is generally regarded as an important determinant of its lethal effects in humans or experimental animals. This study examined the role of superantigenicity in a BALB/c mouse model of lethal TSST-1-induced hypersensitivity to lipopolysaccharide (LPS). In this model, TSST-1 greatly potentiated both LPS-induced lethality, as well as LPS-induced serum tumor necrosis factor alpha (TNF-alpha) activity. Although BALB/c-SCID mice were resistant to these LPS enhancement effects of TSST-1, BALB/c-SCID mice reconstituted with T cells were completely susceptible to the enhancement effect of TSST-1 on LPS-induced serum TNF-alpha. Mice pretreated with cyclosporine (Cs) or neutralizing antibodies against gamma interferon (IFN-gamma) did not develop lethal LPS hypersensitivity when injected with TSST-1, and these agents reduced the enhancement effect of TSST-1 on LPS-induced serum TNF-alpha by 99 and 85%, respectively. Cs pretreatment also completely inhibited the known capacity of TSST-1 to amplify LPS-induced levels of IFN-gamma in serum. In contrast, mice given Cs after a priming injection of TSST-1, but before LPS, still exhibited lethal hypersensitivity to LPS. Cs given after TSST-1 also did not inhibit enhancement of LPS-induced serum TNF-alpha by TSST-1 but inhibited the enhancement effect of TSST-1 on LPS-induced serum IFN-gamma by 50%. These experiments support the theory that TSST-1-induced hypersensitivity to LPS is mediated primarily by IFN-gamma derived from superantigen-activated T cells.

Indexed as

Bacterial ToxinsAdoptive TransferAnimalsAntibodies, MonoclonalCyclosporineEnterotoxinsFemaleHypersensitivityInterferon-gammaLipopolysaccharidesLymphocyte TransfusionMiceMice, Inbred BALB CMice, Inbred C57BLMice, SCIDSuperantigensAntibodies, MonoclonalBacterial ToxinsCyclosporineenterotoxin F, StaphylococcalEnterotoxinsInterferon-gammaLipopolysaccharidesSuperantigensTumor Necrosis Factor-alpha

Identifiers

PMID11179286
PMCPMC98015
OpenAlexW2132352490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.